Endocrine Testing Global Market Report 2025

Description

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

The increasing prevalence of diabetes is expected to drive the growth of the endocrine testing market. Diabetes is a group of diseases characterized by high blood sugar (glucose) levels, and its prevalence is rising due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Endocrine testing, including tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS) reported a significant increase in diabetes cases among individuals under 40, with the number rising from 173,166 in 2022 to 216,440 in 2023. This surge indicates a concerning trend in diabetes prevalence among younger populations. As a result, the growing prevalence of diabetes is fueling the demand for endocrine testing solutions.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30136

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Endocrine Testing Market Growth Rate Analysis
5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Endocrine Testing Total Addressable Market (TAM)

6. Endocrine Testing Market Segmentation

6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Other Types
6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tandem Mass Spectrometry
Immunoassay
Monoclonal And Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Other Technologies
6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinical Laboratories
Diagnostic Centers
Other End-Users
6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Estradiol Test
Urinary Estradiol Test
6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
FSH Serum Test
FSH Urine Test
6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative hCG Test
Qualitative hCG Test
6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
LH Serum Test
LH Urine Test
6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum DHEAS Test
Saliva DHEAS Test
6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Progesterone Test
Urinary Progesterone Test
6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Free Testosterone Test
Total Testosterone Test
6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
TSH Serum Test
TSH Saliva Test
6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Prolactin Test
Plasma Prolactin Test
6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cortisol Test
Insulin Test
Growth Hormone (GH) Test
Aldosterone Test

7. Endocrine Testing Market Regional And Country Analysis

7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Testing Market

8.1. Asia-Pacific Endocrine Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Testing Market

9.1. China Endocrine Testing Market Overview
9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Testing Market

10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Testing Market

11.1. Japan Endocrine Testing Market Overview
11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Testing Market

12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Testing Market

13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Testing Market

14.1. South Korea Endocrine Testing Market Overview
14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Testing Market

15.1. Western Europe Endocrine Testing Market Overview
15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Testing Market

16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Testing Market

17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Testing Market

18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Testing Market

19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Testing Market

20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Testing Market

21.1. Eastern Europe Endocrine Testing Market Overview
21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Testing Market

22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Testing Market

23.1. North America Endocrine Testing Market Overview
23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Testing Market

24.1. USA Endocrine Testing Market Overview
24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Testing Market

25.1. Canada Endocrine Testing Market Overview
25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Testing Market

26.1. South America Endocrine Testing Market Overview
26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Testing Market

27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Testing Market

28.1. Middle East Endocrine Testing Market Overview
28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Testing Market

29.1. Africa Endocrine Testing Market Overview
29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

30.1. Endocrine Testing Market Competitive Landscape
30.2. Endocrine Testing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Testing Market Other Major And Innovative Companies

31.1. Agilent Technologies Inc.
31.2. PerkinElmer Inc.
31.3. BioMerieux SA
31.4. Beckman Coulter Inc.
31.5. Bio-Rad Laboratories Inc.
31.6. SD Biosensor Inc.
31.7. Qiagen N.V.
31.8. Ortho Clinical Diagnostics
31.9. Kronus Inc.
31.10. Randox Laboratories Ltd.
31.11. Fujirebio Diagnostics Inc.
31.12. Inova Diagnostics Inc.
31.13. Sekisui Diagnostics LLC
31.14. Mercodia AB
31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Testing Market

34. Recent Developments In The Endocrine Testing Market

35. Endocrine Testing Market High Potential Countries, Segments and Strategies

35.1 Endocrine Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Endocrine Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Endocrine Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer